Authors
Senior partner, life sciences, WittKieffer
The president and head of U.S. commercial at Astellas. Prior to Astellas, Petroutsas served as senior vice president, U.S. Specialty and Oncology Business, at GSK. There he successfully launched the US Oncology division and focused on commercializing medicines to help many patients with complex diseases in immunology, hepatology, respiratory and renal areas. Before that, he held senior positions at Pfizer and Novartis Oncology.
Nacho Quinones, Ph.D., is a Senior Principal at IQVIA specializing in medical affairs strategy. With more than 15 years across life sciences and management consulting, he designs and executes transformative medical affairs programs, builds tech-enabled capabilities and helps organizations disseminate impactful medical evidence, drawing on deep expertise in operating model design and change management. He holds a Ph.D. in biochemistry from King's College London and a BSc in biochemistry from Imperial College London, alongside professional qualifications in business accounting.
Is vice president, offering development within IQVIA’S global commerce offering business responsible for global launch excellence. Over the past 25 years, she has worked with some of the world’s most successful brands across both the pharma and CPG industries in Europe, the Americas, and Southeast Asia.
Chief Medical and Scientific Officer, Worldwide Clinical Trials
Chief Product & Technology Officer, OptimizeRx
Sean Werner is the Chief Technology Officer of Cell Processing at BioLife Solutions, a leading provider of bioproduction tools and services to the cell and gene therapy and broader biopharma markets. BioLife acquired Sexton Biotechnologies in 2021 where Sean was President of the company known for providing processing and handling solutions for the CGT industry. Sean received his PhD from Purdue University in Biology followed by post-doctoral positions at the Indiana University School of Medicine and Eli Lilly. Sean has previous experience filling various roles in the scientific, global regulatory, and general management functions supporting medical devices, autologous cell therapy, and single use disposable development programs. In his 23 years working in the life science industry, he has guided regenerative medicine research programs, pre-clinical and clinical testing and submission strategies leading to global commercialization of medical devices and bioprocessing tools and successful initiation of multi-national cell therapy clinical studies.
A founding member of TransCelerate BioPharma Inc. and a retired global clinical operations executive. During his career, he led worldwide clinical trial operations at Merck and held senior leadership roles at Sanofi, Genzyme, and Pfizer. He helped shape TransCelerate’s early strategy, governance, and project portfolio and served on its board as treasurer.
Emily Schoenthaler is a content producer for BioPharm International.
She is a senior director in data science and advanced analytics at IQVIA, where she leads a team developing predictive analytics with AI/ML, projections, precision targeting, and advanced statistical modeling. With over 25 years of pharmaceutical industry experience, Zhoi specializes in translating patient-level data into actionable business insights through custom analytical solutions that integrate multiple data sources.
Prior to IQVIA, she held progressive leadership positions at NDC Health, Verispan, and SDI. Zhou holds a master of science in industrial engineering from the University of Alabama and a bachelor of material management from Northern Jiaotong University in Beijing, China.
CEO and board member of Consano Bio. He previously led IMV Inc., a clinical-stage biopharmaceutical company in oncology that was acquired in 2023. Before IMV, Andrew spent 7 years at Celgene, where he led corporate development and pipeline strategy for immunology, as well as business development and strategic alliances, working on deals from discovery to commercialization.
Andrew also spent more than 15 years at Merck, BMS, and Schering Plough in leadership roles across Asia Pacific, Europe and the US.
Consultant, Shabas Solutions LLC
Founder and CEO of NAYA Therapeutics.
Brings more than 22 years of experience in leadership and operational roles across pharmaceutical, healthcare, financial services and automotive industries. As director of New Product Development at IQVIA, he leads product development within Global Market Insights, driving development and commercialization of GenAI solutions while also transforming the flagship IQVIA MIDAS® offering for global pharmaceutical market measurement. His expertise spans end-to-end client engagement management, business development and solution design for complex business challenges across Fortune 500 customers in the U.S., U.K., Europe and APAC regions.
VP, U.S. Thought Leadership & Innovation, IQVIA
Mitja Alexander Linss is the Head of Marketing for Karger Publishers
Rathi Suresh, PhD, is Vice President of Analytics at Komodo Health.
Senior director, video and digital content strategy, within global medical and Evidence at Bayer. His doctoral research examined how health information travelled across mainstream and social media during the COVID-19 pandemic. He is also a co-founder of The Undoctored Truths Alliance — a voluntary, volunteer-led initiative connecting a globally distributed network of trusted professionals (clinicians, scientists, communicators and patient advocates) to counter health misinformation. He writes in a personal capacity; the views expressed are his own.
Yamini Misra, MBA is the Vice President, Management Consulting Practice, AESARA Inc.